Drug profile · INN
belantamab mafodotin-blmf
BLENREP
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
belantamab mafodotin-blmf (BLENREP) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN belantamab mafodotin-blmf
Brand BLENREP
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is belantamab mafodotin-blmf?
belantamab mafodotin-blmf (BLENREP) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for belantamab mafodotin-blmf?
BLENREP is a marketed brand name for belantamab mafodotin-blmf. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of belantamab mafodotin-blmf?
belantamab mafodotin-blmf has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.